Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julianne Barlow"'
Autor:
Grit S. Herter-Sprie, F. Stephen Hodi, Julianne Barlow, Elena Ivanova, Lauren Keogh, Jessie M. English, David A. Barbie, Meghana M. Kulkarni, Christina Almonte, Mark A. Bittinger, William G. Richards, Lynette M. Sholl, Raphael Bueno, Hongye Liu, Kai W. Wucherpfennig, Peter S. Hammerman, Patrick H. Lizotte, Abigail A. Santos, Robert E. Jones, Pasi A. Jänne, Xiaoyun Liao, Adam J. Bass, Kwok-Kin Wong, Shohei Koyama, Mark M. Awad, Scott J. Rodig
Publikováno v:
Cancer Immunology Research. 4:1038-1048
PD-L1 immunohistochemical staining does not always predict whether a cancer will respond to treatment with PD-1 inhibitors. We sought to characterize immune cell infiltrates and the expression of T-cell inhibitor markers in PD-L1–positive and PD-L1
Autor:
Megan E. Cavanaugh, David M. Jackman, William G. Richards, Kwok-Kin Wong, Patrick H. Lizotte, Paul Kirschmeier, Sristi Sharma, David T. Weaver, Kam Sprott, Beow Y. Yeap, Amanda J. Rode, Ritu R. Gill, Julianne Barlow, Abraham Lebenthal, Lucian R. Chirieac, David J. Kwiatkowski, Raphael Bueno
Publikováno v:
Journal of Clinical Oncology. 35:8555-8555
8555 Background: Defactinib is an oral Focal Adhesion Kinase (FAK) inhibitor with preclinical activity in MPM. We assessed responses to defactinib treatment prior to planned surgical resection in naive patients with MPM. Methods: Three cohorts of 10